Andrew is a serial biotech entrepreneur and experienced scientist, working across genetic medicine including RNA therapeutics.

Leveraging his expertise successfully founding and growing companies such as Korro Bio and Judo Bio, Andrew specializes in supporting start-ups and early stage companies to develop robust and effective growth strategies that ensure long-term success. Andrew is also the Founding and Managing Partner at Sunrise BioVentures, an RNA therapeutics accelerator program.

Andrew was awarded a Ph.D from Boston College in the field of bio-organic chemistry, where his work centered around the structure and function of nucleic acids, particularly in RNA aptamer selection, and DNA polymerase base recognition.